These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. [Resection of maxillary nerve neurinoma in the pterygomaxillary fossa via Lefort I transmaxillary approach]. Guyot L; Richard O; Layoun W; Gola R Rev Stomatol Chir Maxillofac; 2003 Sep; 104(4):239-41. PubMed ID: 14631237 [TBL] [Abstract][Full Text] [Related]
64. [Low rectovaginal fistula treated with platelet-rich plasma (PRP)]. Mongardini M; Iachetta RP; Cola A; Maturo A; Giofrè M; Custureri F G Chir; 2009; 30(11-12):507-9. PubMed ID: 20109382 [TBL] [Abstract][Full Text] [Related]
65. [Effect of platelet rich plasma on the regeneration of cavernous nerve: experiment with rats]. Ding XG; Li SW; Zheng XM; Hu LQ; Hu WL; Luo Y Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2578-80. PubMed ID: 19080657 [TBL] [Abstract][Full Text] [Related]
66. Comparison of platelet-rich plasma, bovine porous bone mineral, and guided tissue regeneration versus platelet-rich plasma and bovine porous bone mineral in the treatment of intrabony defects: a reentry study. Lekovic V; Camargo PM; Weinlaender M; Vasilic N; Kenney EB J Periodontol; 2002 Feb; 73(2):198-205. PubMed ID: 11895286 [TBL] [Abstract][Full Text] [Related]
67. A modified tarrsorhaphy technique. Scott AB; Johnson RC Arch Ophthalmol; 1972 Nov; 88(5):530-1. PubMed ID: 4634793 [No Abstract] [Full Text] [Related]
68. Autologous platelet-rich plasma in the treatment of refractory corneal ulcers: A case report. Rechichi M; Ferrise M; Romano F; Gallelli L; Toschi V; Dominijanni A; Meduri A Am J Ophthalmol Case Rep; 2020 Dec; 20():100838. PubMed ID: 32913920 [TBL] [Abstract][Full Text] [Related]
70. Clinical Efficacy of Platelet-Rich Plasma in the Treatment of Neurotrophic Corneal Ulcer. Wróbel-Dudzińska D; Alio J; Rodriguez A; Suchodoła-Ratajewicz E; Kosior-Jarecka E; Rymgayłło-Jankowska B; Ćwiklińska-Haszcz A; Żarnowski T J Ophthalmol; 2018; 2018():3538764. PubMed ID: 30026985 [TBL] [Abstract][Full Text] [Related]
71. Neurotrophic keratopathy secondary to trigeminal nerve aplasia in patient with Goldenhar syndrome. Olavarri González G; García-Valcarcel González B; Baeza Autillo A; Balado Vazquez P Arch Soc Esp Oftalmol; 2016 Apr; 91(4):191-4. PubMed ID: 26819096 [TBL] [Abstract][Full Text] [Related]
72. Re: "tegaderm transparent dressing (3M) for the treatment of chronic exposure keratopathy". Chavez M; Putterman AM; Pak J Ophthalmic Plast Reconstr Surg; 2006; 22(3):236; author reply 236. PubMed ID: 16714946 [No Abstract] [Full Text] [Related]
73. Tegaderm transparent dressing (3M) for the treatment of chronic exposure keratopathy. Airiani S; Braunstein RE; Kazim M; Schrier A; Auran JD; Srinivasan BD Ophthalmic Plast Reconstr Surg; 2003 Jan; 19(1):75-6. PubMed ID: 12544796 [TBL] [Abstract][Full Text] [Related]
74. [Successful treatment of surgically induced necrotizing sclerokeratitis (SINS) with systemic immunosuppresive agents and amniotic membrane grafting]. Cordero-Coma M; Franco-Benito M; García-Ruiz-de-Morales JM; Alonso-Orcajo N; Del Barrio-Manso I Arch Soc Esp Oftalmol; 2009 Nov; 84(11):577-80. PubMed ID: 19967612 [TBL] [Abstract][Full Text] [Related]
75. Re: Arvola R. P., Robciuc A., Holopainen J. M. Matrix Regeneration Therapy: A Case Series of Corneal Neurotrophic Ulcers. Kymionis GD; Liakopoulos DA; Mikropoulos DG Cornea; 2016 Sep; 35(9):e28. PubMed ID: 27387568 [No Abstract] [Full Text] [Related]
76. A surgical approach to the ophthalmic-maxillary nerve trunks in the rat. Gregg JM J Dent Res; 1973; 52(2):392. PubMed ID: 4511325 [No Abstract] [Full Text] [Related]
77. [Healing of a resistant neurotrophic corneal ulcer using a new matrix therapy agent]. Pison A; Feumi C; Bourges JL J Fr Ophtalmol; 2014 Sep; 37(7):e101-4. PubMed ID: 25064515 [No Abstract] [Full Text] [Related]